Frontlight ResearchEarly access
Childhood cancers trials in France
207 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleLong-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Where
- Creteil Cedex, Dijon, Lille, Montpellier Cedex 5, Nantes, Nice, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Rennes Cedex 9, Rouen Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy, Villejuif
- People
- 1,541 worldwide
- Run by
- Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Bordeaux, Lyon, Marseille, Nantes, Villejuif
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 1/2Taking peopleA Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Where
- Bordeaux, Lyon, Marseille, Nantes, Paris, Villejuif
- Age
- 1 month to 17 years
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07630974 · EU 2025-522339-32-00 - No phaseTaking peopleMet Non Small Cell Cancer Registry (MOMENT)
- Where
- Cholet, Lille, Lorient, Lyon, Paris, Rennes, Toulouse
- People
- 700 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT05376891 - Phase 1Taking peoplePhase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- Where
- Marseille, Villejuif
- Age
- 24 months to 18 years
- People
- 20 worldwide
- Run by
- ITM Solucin GmbH
See details and how to joinNCT06441331 · EU 2024-512831-66-00 - No phaseTaking peopleAQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database
- Where
- Saint-Affrique
- People
- 120
- Run by
- AstraZeneca
See details and how to joinNCT06548152 - No phaseTaking peopleMenin Inhibitors in Pediatric Relapsed or Refractory Acute Leukemia
- Where
- Strasbourg
- Age
- 0 years to 17 years
- People
- 10
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07898436 - Phase 3Taking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Amiens, ANGERS Cedex 09, Besancon Cedex, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble cedex 09, Lille, Limoges, Lyon, Marseille, Montpellier Cedex 05, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Strasbourg Cedex 2, Toulouse, Tours, Vanoeuvre les Nancy
- Age
- 1 year to 64 years
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - Phase 3Taking peopleFight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
- Where
- Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Dijon, Grenoble, La Réunion, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Saint-Herblain, Strasbourg, Toulouse, Tours, Vandœuvre-lès-Nancy, Villejuif
- Age
- 4 years and over
- People
- 530 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864 - No phaseTaking peopleCharacterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry
- Where
- Strasbourg
- Age
- 1 year and over
- People
- 50
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07895901 - No phaseTaking peopleRegistry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)
- Where
- Vandœuvre-lès-Nancy
- People
- 3,000
- Run by
- Central Hospital, Nancy, France
See details and how to joinNCT03410394 - Phase 3Taking peopleInternational study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
- Where
- Amiens Cedex 1, Angers, Besancon Cedex, Bordeaux, Brest, Caen Cedex 9, Clermont-Ferrand, Dijon, Grenoble Cedex 9, Lille Cedex, Lyon, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen Cedex, Saint-Denis, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy, Villejuif
- Age
- Up to 17 years
- People
- 137 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501454-11-00 - Phase 3Taking peopleBiological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
- Where
- Amiens Cedex 1, Angers, Besançon, Bobigny, Bordeaux, Bordeaux Cedex, Brest, Bron, Caen, Caen Cedex 5, Clermont-Ferrand, Clichy, Dijon, Grenoble Cedex 9, La Réunion., La Tronche, Le Kremlin Bicetre Cedex, Lille, Limoges, Lyon, Marseille, Metz Cedex 03, Montpellier, Montpellier Cedex 5, Nancy, Nice, NICE, Nice Cedex 2, Paris, Pessac, Poitiers, Reims Cedex, Rennes, Rennes Cedex, Rouen Cedex, Saint-Denis, Saint-Herblain Cedex, Saint-Pierre, Saint-Pierre Cedex, Saint-Priest-en-Jarez, STRASBOURG, Alsace, Strasbourg Cedex 2, Suresnes, Toulouse, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy, Vandouvre Les Nancy, Villejuif
- Age
- 6 months and over
- People
- 433 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05476939 · EU 2023-506027-29-00 - Phase 3Taking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Amiens Cedex 1, Angers, Bayonne, Caen Cedex 9, Le Chesnay Rocquencourt, Le Mans, Lille Cedex, Limoges Cedex 1, Marseille, Nice, Paris, Pessac, Pierre-Bénite, Rouen Cedex, Strasbourg Cedex 2
- Age
- 12 years and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - Phase 3Not yet taking people in FranceComparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
- Where
- Villejuif
- Age
- Up to 5 years
- People
- 96 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT07291102 · EU 2024-517133-40-00 - Phase 2/3Not yet taking people in FranceFramework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Where
- Paris
- Age
- 3 months to 25 years
- People
- 1,000 worldwide
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00 - Phase 3CompletedA Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- Where
- Lille, Paris, Pessac
- People
- 115 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT03394365 · EU 2024-516622-57-00 - Phase 3Taking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Amiens Cedex 1, Besancon Cedex, Bordeaux, Grenoble Cedex 9, Lille Cedex, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen Cedex, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Age
- 1 day to 1 year
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - Phase 2Taking peopleAntiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Where
- Lille, Lyon, Marseille, Strasbourg Cedex 2
- Age
- Up to 19 years
- People
- 232 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT01356290 · EU 2024-515626-92-00 - Phase 1/2Taking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Caen, Marseille, Nantes, Paris, Pierre-Bénite, Toulouse Cedex 9
- Age
- 12 years and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - Phase 1/2Taking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Créteil, Dijon, Lille, Pierre-Bénite, Villejuif
- Age
- 12 years and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - Phase 1/2Taking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Paris, Pessac, Pierre-Bénite, Villejuif
- Age
- 30 days and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - Phase 1Taking peoplePhase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- Where
- Pierre-Bénite
- Age
- 15 years and over
- People
- 282 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06276491 - Phase 1Taking peopleZiftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
- Where
- Nantes, Paris
- Age
- 0 years to 21 years
- People
- 20 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT06376162 · EU 2023-505262-28-00 - Phase 1/2Not yet taking people in FranceStudy of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
- Where
- Bordeaux, Lyon, Marseille, Nantes, Paris, Pessac, Rennes Cedex 9
- Age
- Up to 64 years
- People
- 22 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522019-40-00